Urological aspects of HIV and AIDS

Area of Science:

• Urology
• Infectious Diseases
• Oncology

Background:

• Highly active antiretroviral therapy (HAART) has significantly reduced opportunistic infections and certain malignancies in HIV-infected individuals.
• Despite HAART, advanced cervical cancer remains associated with severe urological complications like renal failure and fistulas.
• HIV infection and its treatments can lead to renal failure, manageable with dialysis and transplantation.

Purpose of the Study:

• To highlight the evolving urological challenges and management strategies for HIV-positive patients with increased life expectancy due to HAART.
• To emphasize that HIV status should not preclude patients from receiving standard cancer and erectile dysfunction treatments.
• To address surgical safety considerations for HIV-infected patients and healthcare providers.

Main Methods:

• Review of current medical literature and clinical guidelines concerning HIV management and urological care.
• Analysis of the impact of HAART on HIV-related comorbidities and life expectancy.
• Discussion of treatment protocols for urological conditions, cancers, and erectile dysfunction in the context of HIV.

Main Results:

• HAART has improved survival and life expectancy for HIV patients, leading to a greater prevalence of age-related and general urological conditions.
• HIV-infected patients require careful management of potential drug interactions and side effects during cancer chemotherapy.
• The risk of HIV transmission during surgery is minimal in patients with fully suppressed viral loads on HAART.

Conclusions:

• HIV-positive individuals now present with common urological problems, necessitating comprehensive care comparable to HIV-negative patients.
• Standard cancer and erectile dysfunction treatments should be offered to HIV patients, with careful consideration of potential risks and interactions.
• Urologists play a vital role in managing the urological health of the growing HIV-positive population.